GX BIO LABS · Product artwork
This listing is CJC-1295 No DAC. The linked human study concerns the related, long-acting albumin-binding CJC-1295 compound and is provided as context, not direct evidence for the no-DAC material.
10 available
View COA for 10 mg1 batch report available
Listed identity: CJC-1295 No DAC. Exact sequence and molecular specification should be confirmed; do not substitute data for albumin-binding CJC-1295 with DAC.
Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
1 report is available for this strength. Match the batch number on your supplied material.
View available COAsThe No DAC designation is essential when interpreting CJC-1295 literature. In the linked human physiology study, the investigated compound bound to albumin and produced prolonged exposure. Researchers measured overnight growth hormone secretion and IGF-I in healthy men. That albumin-binding material differs from the no-DAC designation on this listing, so its duration of action and hormone findings cannot simply be assigned to this product. An exact molecular specification is needed to map research accurately. This page includes the paper to make the distinction visible; it does not present a verified direct trial of the listed no-DAC material.
Listed identity: CJC-1295 No DAC. Exact sequence and molecular specification should be confirmed; do not substitute data for albumin-binding CJC-1295 with DAC.
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Healthy men underwent measurements of growth hormone secretion after long-acting, albumin-binding CJC-1295. This paper concerns the DAC form and is not a direct study of the no-DAC product listed here.
Read studyCJC-1295 No DAC is currently listed in 5 mg, 10 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
1 laboratory report is published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.
A catalogue listing is not a laboratory measurement. Check original documentation for the selected strength and batch before relying on identity, purity or quantity information.
Tesamorelin is a growth hormone-releasing hormone analogue studied in defined clinical populations, particularly people with HIV-associated abdominal fat accumulation. Published findings concern the study formulations and do not establish the properties of this research vial.
Ipamorelin is a synthetic peptide studied as a growth hormone secretagogue and ghrelin-receptor agonist. Its literature includes animal pharmacology and a human trial of postoperative bowel function, with distinct endpoints and limitations.
HGH denotes human growth hormone. Clinical research on recombinant growth hormone formulations, including somatropin, provides endocrine context but does not validate the identity, potency or clinical suitability of a research vial.